CLVLF

 
Ordinary Shares International Reporting
Pink Current Information
Contact Info
  • Level 5
  • 160 Queen Street
  • Melbourne, VIC 3000
  • Australia

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
CIK 0001290877
Fiscal Year End 6/30
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: Australia
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Philippe Wolgen CEO
Darren Keamy CFO
Colin Mackie Director, Bus. Dev.
Company Directors
Philippe Wolgen
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Formerly=EpiTan Ltd. until 3-06
CLVLF Security Details Other Company Securities
Share Structure
Market Value1 $180,398,400 a/o Jun 27, 2017
Authorized Shares Not Available
Outstanding Shares 38,220,000 a/o Dec 31, 2013
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
CUV - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 166 (-87.85%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security